NCT06527456 Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening
| NCT ID | NCT06527456 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Intercommunal Creteil |
| Condition | Cervical Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 11,200 participants |
| Start Date | 2026-01-21 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 11,200 participants in total. It began in 2026-01-21 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In France, cervical cancer is the 12th most common female cancer with nearly 3,000 new cases per year. Since 2018, a national Organized Cervical Cancer Screening program (DOCCU) has been set up and concerns all asymptomatic women aged 25 to 65. This program, managed by the Regional Cancer Screening Coordination Centers (CRCDC), invites women who have not taken a sample within the recommended time frame to consult for screening. However, only 59% of patients participated. The intervention of the general practitioner, an essential player in prevention, could allow for better awareness. The objective of the INDIGO study is to evaluate the effectiveness of the intervention of a general practitioner on the participation rate in the DOCCU of patients who are not up to date with their screening.
Eligibility Criteria
Inclusion Criteria: * Woman aged 25 to 65 living in Ile-De-France * Eligible for DOCCU (not hysterectomized, not followed for a pre-cancerous or cancerous lesion of the cervix) * Having declared the investigating general practitioner as a treating physician (MT) and whose MT practices in the territory of a CPTS in the UPEC area * Affiliate to a social security scheme or beneficiary of such a scheme Exclusion Criteria: * Patient already included in a study on DOCCU * Patient excluded from organized screening (cervical cancer, hysterectomy). * Patient's opposition to participating in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06527456 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 65 Years, studying Cervical Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06527456 currently recruiting?
Yes, NCT06527456 is actively recruiting participants. Contact the research team at emilie.ferrat@u-pec.fr for enrollment information.
Where is the NCT06527456 trial being conducted?
This trial is being conducted at Créteil, France.
Who is sponsoring the NCT06527456 clinical trial?
NCT06527456 is sponsored by Centre Hospitalier Intercommunal Creteil. The trial plans to enroll 11,200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.